biote Corp. (BTMD)
NASDAQ: BTMD · IEX Real-Time Price · USD
5.80
-0.07 (-1.19%)
Mar 28, 2024, 4:00 PM EDT - Market closed

biote Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Cash & Equivalents
8979.2326.7717.21
Cash & Cash Equivalents
8979.2326.7717.21
Cash Growth
12.33%196.01%55.54%-
Receivables
6.816.955.234.72
Inventory
17.3111.189.624.32
Other Current Assets
9.233.825.471.57
Total Current Assets
122.34101.1847.0927.82
Property, Plant & Equipment
3.13.562.692.17
Goodwill and Intangibles
4.975.074.552.6
Other Long-Term Assets
24.881.8400
Total Long-Term Assets
32.9510.477.254.77
Total Assets
155.3111.6554.3332.59
Accounts Payable
4.164.114.352.45
Deferred Revenue
4.322.892.512.88
Current Debt
6.566.425.255.24
Other Current Liabilities
7.185.355.211.15
Total Current Liabilities
22.2218.7717.3111.71
Long-Term Debt
108.31114.0132.0937.12
Other Long-Term Liabilities
61.3237.140.80.84
Total Long-Term Liabilities
169.63151.1532.8937.95
Total Liabilities
191.84169.9250.2149.66
Total Debt
114.87120.4337.3442.36
Debt Growth
-4.61%222.53%-11.85%-
Retained Earnings
-29.39-44.464.17-17.05
Comprehensive Income
-0.01-0.01-0.04-0.02
Shareholders' Equity
-29.4-44.464.13-17.08
Net Cash / Debt
-25.87-41.2-10.57-25.15
Net Cash Per Share
-1.01-5.11-10.79-25.67
Working Capital
100.1382.4129.7716.11
Book Value Per Share
-1.14-5.524.21-17.43
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).